PubRank

M C Morelli

Author PubWeight™ 19.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group. Chest 2000 2.04
2 The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology 1995 1.88
3 Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 2010 1.18
4 Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant 2011 1.18
5 Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1996 1.01
6 High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? Gut 2006 1.00
7 Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am J Respir Crit Care Med 1994 0.92
8 Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation 1999 0.87
9 Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant 1999 0.87
10 Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation. Aliment Pharmacol Ther 2008 0.81
11 Effects of "systemic" budesonide concentrations on in vitro allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Allergy 1995 0.81
12 Letter: calcineurin inhibitor level reduction during treatment with sofosbuvir in liver transplanted patients. Aliment Pharmacol Ther 2014 0.81
13 Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. Transplant Proc 2010 0.81
14 Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response. Dig Dis Sci 1994 0.80
15 Budesonide down-regulates eosinophil locomotion but has no effects on ECP release or on H2O2 production. Lung 1999 0.78
16 Non-specific bronchial hyperresponsiveness induced by occupational exposure to different irritants. Clin Exp Allergy 1989 0.78
17 Comparison between eosinophilic markers in induced sputum and blood in asthmatic patients. Clin Exp Allergy 1998 0.78
18 Severe and relapsing upper gastrointestinal bleeding in a patient with Glanzmann's thrombasthenia. Dig Dis Sci 2000 0.77
19 Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide. Clin Exp Allergy 1996 0.75
20 Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. Dig Liver Dis 2014 0.75
21 Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma. Hepatogastroenterology 1989 0.75
22 Pseudotumoral appearance of a duodenal diverticulum by ultrasonography: a case report. J Ultrasound Med 1993 0.75
23 [Diagnostic usefulness of cerebral single photon emission computed tomography (SPECT). Comparison with axial computed tomography]. Minerva Med 1988 0.75
24 Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase. Eur J Clin Pharmacol 1994 0.75
25 HBV-related cutaneous periarteritis nodosa in a patient 16 years after renal transplantation: efficacy of lamivudine. J Nephrol 2001 0.75
26 Beware of TIPS in liver transplant candidates. Transjugular Intrahepatic Portosystemic Shunt. Hepatogastroenterology 1997 0.75
27 Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Ann Allergy Asthma Immunol 1995 0.75